Access cutting-edge breast cancer treatment through this clinical trial at a research site in Anaheim. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Anaheim at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This is a multicenter randomized, open label study to evaluate overall survival with the Bria-IMT regimen in combination with Checkpoint Inhibitor \[Retifanlimab\], versus Treatment of Patients'/Physicians' Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies available.
Sponsor: BriaCell Therapeutics Corporation
Check if you qualify for this breast cancer clinical trial in Anaheim, CA
If you're searching for breast cancer treatment options in Anaheim, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anaheim research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.